Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Therapeutic Drug Services In Europe
5 services found
by:Eurofins Scientific based inKraainem, BELGIUM
Global coverage; By utilizing our wholly-owned harmonized laboratory facilities in the United States, Europe, Singapore and China, Eurofins Central Laboratory is able to accomodate clinical trials of any nature, size, foot print or complexity. Especially with the increasing number of study protocols that involve a variety in esoteric testing like therapeutic drug ...
by:Envigo based inCambridgeshire, UNITED KINGDOM
There are many qualities that differentiate a chemical from a drug. From therapeutic efficacy to it"s first-pass metabolism in man, there are a variety of characteristics that make it more, or less, likely that a chemical will make an effective and safe therapeutic. At Huntingdon Life Sciences, we recognise that it can be vitally important to ...
by:Oncodesign based inDijon, FRANCE
DRIVE-IDDS, an integrated drug discovery solution: a complete continuum from target to clinical candidate. ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Creative Biolabs has extensive experience to offer the novel human or humanized antibody services for either therapeutic or laboratory applications. We have three routes in developing human antibodies. The first and most straightforward method is to screen our human antibody libraries. The second method is to immunize premade “humanized” mice and then raise hybridoma cell lines [or to ...
by:Revvity Gene Delivery (formerly SIRION Biotech) based inHamburg, GERMANY
In the discovery of oncology therapeutics, Antibody-drug conjugates (ADCs) are rapidly gaining momentum, with hundreds of candidates advancing through clinical development. Whether your priority lies in assessing the epitope binding of your construct, evaluating the cytotoxic potency of the payload, or scrutinizing the efficacy of the linker in cleaving, each ...